Philips strengthens sleep and respiratory care portfolio with launch of Oxygenate 5 in India

As India faces a significant burden of chronic respiratory conditions Philips, a global leader in health technology, launches Oxygenate 5 in India. Designed for people requiring long-term supplemental oxygen at home, the new stationary oxygen concentrator brings together dependable oxygen delivery with patient-centric features designed around the everyday experience of therapy.

As per reports, Chronic obstructive pulmonary disease (COPD) affects around 13% of adults in India, rising to 27% among those aged 60 and above, highlighting the significant burden of the disease. For patients with chronic respiratory conditions who develop severe hypoxaemia, long-term oxygen therapy can be an important part of ongoing care. Oxygenate 5 is designed to support these long-term oxygen therapy needs, including in the home environment.

As respiratory care increasingly extends beyond hospitals, there is a growing focus on making long-term oxygen therapy easier to manage at home. Oxygenate 5 is designed with the everyday needs of patients and caregivers in mind, offering quieter operation at less than 40 dB, an easy-to-read digital flowmeter and simplified routine maintenance.

Oxygenate 5 delivers continuous oxygen flow from 0.5 to 5 L/min. Its digital flow display is designed to make monitoring and setting oxygen flow easier. Oxygenate 5 also helps DMEs and clinicians manage patient care and is supported by customer service that customers can rely on. It is designed with nine levels of filtration and ships with four additional air inlet filters and one additional air filter. These user-replaceable filters may help lower consumable purchases and operational cost, and support ease of maintenance.